Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Thomas_Madden
|
| gptkbp:collaboratedWith |
gptkb:Pfizer
gptkb:BioNTech |
| gptkbp:country |
gptkb:Canada
|
| gptkbp:focusesOn |
RNA therapeutics
|
| gptkbp:founded |
2009
|
| gptkbp:foundedBy |
gptkb:Thomas_Madden
|
| gptkbp:headquarters_location |
gptkb:Vancouver
|
| https://www.w3.org/2000/01/rdf-schema#label |
Acuitas Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:specializesIn |
lipid nanoparticle technology
|
| gptkbp:technology |
gptkb:Pfizer-BioNTech_COVID-19_vaccine
|
| gptkbp:website |
https://acuitastx.com/
|
| gptkbp:bfsParent |
gptkb:ALC-0159
gptkb:ALC-0315 |
| gptkbp:bfsLayer |
6
|